The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 6, Pages 745
Publisher
MDPI AG
Online
2019-05-29
DOI
10.3390/cancers11060745
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression
- (2018) Hussein F. Aqbi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases
- (2018) Arnaud Pommier et al. SCIENCE
- The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
- (2018) Jordan A. Krall et al. Science Translational Medicine
- The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells
- (2018) Karen Legler et al. Cell Death & Disease
- Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
- (2018) Jan-Paul Gundlach et al. BMC CANCER
- IL-1 and IL-1 regulatory pathways in cancer progression and therapy
- (2017) Alberto Mantovani et al. IMMUNOLOGICAL REVIEWS
- The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
- (2017) Torsten Hartwig et al. MOLECULAR CELL
- Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
- (2017) Oliver G McDonald et al. NATURE GENETICS
- Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection
- (2017) Cui Yang et al. Oncotarget
- The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma
- (2017) Lennart Lenk et al. OncoImmunology
- Borderline resectable pancreatic cancer
- (2016) Thilo Hackert et al. CANCER LETTERS
- Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress
- (2016) Samer Tohme et al. CANCER RESEARCH
- Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver
- (2016) Barbara Grünwald et al. GASTROENTEROLOGY
- Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis
- (2016) Sebastian R. Nielsen et al. NATURE CELL BIOLOGY
- Kupffer cells decrease metastasis of colon cancer cells to the liver in the early stage
- (2016) HIDEKI MATSUMURA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis
- (2015) Silvia von Karstedt et al. CANCER CELL
- Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
- (2015) Bruno Costa-Silva et al. NATURE CELL BIOLOGY
- TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model
- (2015) Hendrik Fritsche et al. Oncotarget
- Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis
- (2014) Ole Helm et al. INTERNATIONAL JOURNAL OF CANCER
- Intensity of Follow-up after Pancreatic Cancer Resection
- (2013) Jason A. Castellanos et al. ANNALS OF SURGICAL ONCOLOGY
- Role of hepatic resident and infiltrating macrophages in liver repair after acute injury
- (2013) Qiang You et al. BIOCHEMICAL PHARMACOLOGY
- Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family
- (2013) K Azijli et al. CELL DEATH AND DIFFERENTIATION
- Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review
- (2013) Michael Retsky et al. CURRENT MEDICINAL CHEMISTRY
- Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer
- (2013) Philippe Rougier et al. EUROPEAN JOURNAL OF CANCER
- Nuclear Death Receptor TRAIL-R2 Inhibits Maturation of Let-7 and Promotes Proliferation of Pancreatic and Other Tumor Cells
- (2013) Verena Haselmann et al. GASTROENTEROLOGY
- Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
- (2013) Andrew D. Rhim et al. GASTROENTEROLOGY
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells
- (2012) K. Azijli et al. JOURNAL OF CELL SCIENCE
- Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis
- (2010) Patrice Forget et al. ANESTHESIA AND ANALGESIA
- Dexamethasone reduces tumor recurrence and metastasis after pancreatic tumor resection in SCID mice
- (2010) Jan-Hendrik Egberts et al. CANCER BIOLOGY & THERAPY
- Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells
- (2010) Frederik J.H. Hoogwater et al. GASTROENTEROLOGY
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5
- (2010) Johannes Lemke et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Activation of the Akt Survival Pathway Contributes to TRAIL Resistance in Cancer Cells
- (2010) Jing Xu et al. PLoS One
- Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
- (2009) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Anti-Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis
- (2008) J.-H. Egberts et al. CANCER RESEARCH
- TNF: A master switch for inflammation to cancer
- (2008) Gautam Sethi Frontiers in Bioscience-Landmark
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started